Skip to main content

XL184 20mg Pill: gray, capsule/oblong, 19mm

Generic Name: cabozantinib

The pill with imprint XL184 20mg (Gray, Capsule/Oblong, 19mm) has been identified as Cometriq 20 mg and is used for Thyroid Cancer. It belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors and is not a controlled substance.

Images for XL184 20mg

Cometriq

Generic Name
cabozantinib
Imprint
XL184 20mg
Strength
20 mg
Color
Gray
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Exelixis, Inc.
National Drug Code (NDC)
42388-0014
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, sodium starch glycolate type A potato, silicon dioxide, stearic acid, gelatin, ferrosoferric oxide, titanium dioxide, shellac, butyl alcohol, isopropyl alcohol, propylene glycol, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.